These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38858148)

  • 1. COVID-19 vaccine uptake among Ontario physicians: a descriptive population-based retrospective cohort study.
    Liu CW; Jeyakumar N; McArthur E; Sontrop JM; Myran DT; Schwartz KL; Sood MM; Tanuseputro P; Garg AX
    BMJ Open; 2024 Jun; 14(6):e080461. PubMed ID: 38858148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccine coverage and factors associated with vaccine uptake among 23 247 adults with a recent history of homelessness in Ontario, Canada: a population-based cohort study.
    Shariff SZ; Richard L; Hwang SW; Kwong JC; Forchuk C; Dosani N; Booth R
    Lancet Public Health; 2022 Apr; 7(4):e366-e377. PubMed ID: 35278362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 testing, infection and outcomes among Ontario physicians: a descriptive population-based cohort study.
    Liu CW; Jeyakumar N; McArthur E; Sontrop JM; Myran DT; Schwartz KL; Sood MM; Tanuseputro P; Garg AX
    CMAJ Open; 2022; 10(3):E657-E665. PubMed ID: 35853660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine equity: a retrospective population-based cohort study examining primary series and first booster coverage among persons with a history of immigration and other residents of Ontario, Canada.
    Wanigaratne S; Lu H; Gandhi S; Shetty J; Stukel TA; Piché-Renaud PP; Brandenberger J; Abdi S; Guttmann A
    Front Public Health; 2023; 11():1232507. PubMed ID: 37744516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    Chung H; He S; Nasreen S; Sundaram ME; Buchan SA; Wilson SE; Chen B; Calzavara A; Fell DB; Austin PC; Wilson K; Schwartz KL; Brown KA; Gubbay JB; Basta NE; Mahmud SM; Righolt CH; Svenson LW; MacDonald SE; Janjua NZ; Tadrous M; Kwong JC;
    BMJ; 2021 Aug; 374():n1943. PubMed ID: 34417165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada.
    Oliver MJ; Thomas D; Balamchi S; Ip J; Naylor K; Dixon SN; McArthur E; Kwong J; Perl J; Atiquzzaman M; Singer J; Yeung A; Hladunewich M; Yau K; Garg AX; Leis JA; Levin A; Krajden M; Blake PG
    J Am Soc Nephrol; 2022 Apr; 33(4):839-849. PubMed ID: 35264455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period.
    Wing S; Thomas D; Balamchi S; Ip J; Naylor K; Dixon SN; McArthur E; Kwong JC; Perl J; Atiquzzaman M; Yeung A; Yau K; Hladunewich MA; Leis JA; Levin A; Blake PG; Oliver MJ
    Clin J Am Soc Nephrol; 2023 Apr; 18(4):491-498. PubMed ID: 36723290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.
    Buchan SA; Chung H; Brown KA; Austin PC; Fell DB; Gubbay JB; Nasreen S; Schwartz KL; Sundaram ME; Tadrous M; Wilson K; Wilson SE; Kwong JC
    JAMA Netw Open; 2022 Sep; 5(9):e2232760. PubMed ID: 36136332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Health Care Visits for Mental Health and Substance Use During the COVID-19 Pandemic in Ontario, Canada.
    Myran DT; Cantor N; Rhodes E; Pugliese M; Hensel J; Taljaard M; Talarico R; Garg AX; McArthur E; Liu CW; Jeyakumar N; Simon C; McFadden T; Gerin-Lajoie C; Sood MM; Tanuseputro P
    JAMA Netw Open; 2022 Jan; 5(1):e2143160. PubMed ID: 35061041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study.
    Richard L; Holland A; Aghanya V; Campitelli MA; Hwang SW
    Front Public Health; 2024; 12():1426152. PubMed ID: 39035175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
    Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC
    JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy.
    Jorgensen SCJ; Drover SSM; Fell DB; Austin PC; D'Souza R; Guttmann A; Buchan SA; Wilson SE; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC
    JAMA Pediatr; 2023 Dec; 177(12):1314-1323. PubMed ID: 37870875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis.
    Alcantara M; Koh M; Park AL; Bril V; Barnett C
    JAMA Netw Open; 2023 Apr; 6(4):e239834. PubMed ID: 37097637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' perspectives on COVID-19 vaccinations for children: a qualitative exploration in Ontario, Canada.
    Hodwitz K; Wigle J; Juando-Prats C; Allan K; Li X; Fallon B; Birken CS; Maguire JL; Parsons JA
    BMJ Open; 2024 Jul; 14(7):e081694. PubMed ID: 39025822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV.
    Hechter RC; Qian L; Liu IA; Sy LS; Ryan DS; Xu S; Williams JTB; Klein NP; Kaiser RM; Liles EG; Glanz JM; Jackson LA; Sundaram ME; Weintraub ES; Tseng HF
    JAMA Netw Open; 2024 Jun; 7(6):e2415220. PubMed ID: 38842808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How are physicians delivering palliative care? A population-based retrospective cohort study describing the mix of generalist and specialist palliative care models in the last year of life.
    Brown CR; Hsu AT; Kendall C; Marshall D; Pereira J; Prentice M; Rice J; Seow HY; Smith GA; Ying I; Tanuseputro P
    Palliat Med; 2018 Sep; 32(8):1334-1343. PubMed ID: 29886804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.